July 31, 2018 / 6:44 AM / 5 months ago

Indivior says U.S. court rules against generic rival's appeal

July 31 (Reuters) - Indivior Plc said on Tuesday a U.S. court ruled against Dr. Reddy’s Laboratories appeal for lifting the preliminary injunction on the rival’s copycat opioid addiction treatment in the United States.

The British drugmaker was granted a preliminary injunction earlier this month that prevented Dr. Reddy’s from selling its copycat version. (Reporting by Sangameswaran S in Bengaluru; Editing by Amrutha Gayathri)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below